A Study to Determine the Clinical Safety/Tolerability and Exploratory Efficacy of EHT 0202 as Adjunctive Therapy to Acetylcholinesterase Inhibitor in Mild to Moderate Alzheimer's Disease (EHT0202/002)

This study has been completed.
Sponsor:
Information provided by:
Exonhit
ClinicalTrials.gov Identifier:
NCT00880412
First received: April 10, 2009
Last updated: September 18, 2009
Last verified: September 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2009
  Primary Completion Date: June 2009 (Final data collection date for primary outcome measure)